Palvella Therapeutics (PVLA) EBITDA Margin (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -9,162.00 |
| Jun 30, 2023 | 71,109.00 |
| Sep 30, 2022 | -350,524.00 |
| Jun 30, 2022 | -26,226.00 |
| Mar 31, 2022 | 14,240.00 |
| Dec 31, 2021 | 39,276.00 |
| Sep 30, 2021 | 2,813.00 |
| Jun 30, 2021 | -58,025.00 |
| Mar 31, 2021 | 71,291.00 |
| Dec 31, 2020 | -26,485.00 |
| Sep 30, 2020 | -43,382.00 |
| Jun 30, 2020 | -2,123.00 |
| Mar 31, 2020 | 4,637.00 |
| Dec 31, 2019 | -6,386.00 |
| Sep 30, 2019 | 22,888.00 |
| Jun 30, 2019 | -12,246.00 |
| Mar 31, 2019 | 182,490.00 |
| Dec 31, 2018 | -185,569.00 |
| Sep 30, 2018 | -10,681.00 |
| Jun 30, 2018 | 26,799.00 |
| Mar 31, 2018 | -26,976.00 |
| Dec 31, 2017 | 21,892.00 |
| Sep 30, 2017 | 38,908.00 |
| Jun 30, 2017 | 1,254.00 |
| Mar 31, 2017 | -35,652.00 |
| Dec 31, 2016 | 55,208.00 |
| Sep 30, 2016 | -24,681.00 |
| Jun 30, 2016 | -18,879.00 |
| Mar 31, 2016 | -95,748.00 |
| Dec 31, 2015 | 154,187.00 |
| Sep 30, 2015 | 126,986.00 |
| Jun 30, 2015 | -50,484.00 |
| Sep 30, 2014 | -943,609.00 |